Daplyza M 5/850 mg Tablet – Dual-Action Glucose Control

  • Combination of dapagliflozin (5 mg) + metformin (850 mg) for type 2 diabetes
  • Helps manage glucose, supports kidney and cardiovascular health
In stock
9 People are viewing this right now
Sale price Rs.302.00 PKR
Add to Wishlist

Daplyza M 5/850 mg Tablet – Dual-Action Glucose Control

Daplyza M 5/850 mg Tablet – Dual-Action Glucose Control

Rs.302.00

Daplyza M 5/850 mg Tablet – Effective Combination for Type 2 Diabetes

Daplyza M is a fixed-dose tablet combining dapagliflozin (5 mg), an SGLT2 inhibitor, with metformin HCl (850 mg), a biguanide. 
This dual therapy works in two complementary ways: dapagliflozin reduces blood sugar by increasing the removal of glucose through urine, while metformin lowers glucose production in the liver and improves the body’s response to insulin.
It’s used in patients with type 2 diabetes when metformin alone is not enough, thereby providing stronger glycemic control and reducing the risk of long-term complications.

  • Strong, dual-mechanism blood sugar lowering 
  • May support weight loss owing to glucose excretion
  • Takes advantage of both SGLT2 inhibition and improved insulin sensitivity
  • Once-daily dosing for convenience
  • Manufactured by Getz Pharma, a reputable company Dawaabhi

  1. Take one tablet daily, or as prescribed by your healthcare provider. 
  2. You can take it with or without food, but taking metformin with food helps reduce stomach upset. 
  3. Swallow the tablet whole with a full glass of water — do not chew or crush. 
  4. Maintain regular diet and exercise as part of your diabetes management plan — this drug works best in combination with lifestyle changes.
  5. Do not stop taking the medicine on your own — any dose change or discontinuation should be done under medical supervision.

Q1: What is Daplyza M 5/850 mg used for?
A1: It’s used to manage type 2 diabetes by lowering blood sugar levels more effectively than either dapagliflozin or metformin alone.

Q2: Why are dapagliflozin and metformin combined in one tablet?
A2: This combination addresses blood sugar from two angles: dapagliflozin helps kidneys clear glucose, and metformin reduces production and improves insulin sensitivity. The combo improves glucose control and may help reduce complications.

Q3: What are common side effects?
A3: Increased urination, nausea, diarrhea, abdominal discomfort, and dizziness are common. More serious risks include urinary infections and lactic acidosis (rare). 

Q4: Do I need monitoring while on this drug?
A4: Yes — your kidney function (eGFR), hydration status, and signs of lactic acidosis should be regularly checked. 

Q5: Can this help me lose weight?
A5: It may contribute to modest weight loss, because dapagliflozin causes glucose to be excreted in urine, reducing overall calorie load. 

Dapagliflozin — 5 mg
Metformin HCl — 850 mg
Plus inactive excipients for the film-coated tablet.

  • Use only under prescription — not suitable for type 1 diabetes. 
  • Monitor kidney function (eGFR) because both dapagliflozin and metformin are affected by renal status. 
  • Risk of dehydration: ensure adequate fluid intake, as dapagliflozin increases urination. 
  • Be careful if you have a history of urinary tract or genital infections — SGLT2 inhibitors increase this risk. 
  • Risk of lactic acidosis from metformin (rare but serious) — watch for signs like muscle pain, breathing difficulty, or unusual weakness. 
  • Not recommended in severe renal impairment or for patients on dialysis. 
  • Avoid excessive alcohol consumption, which may increase acidosis risk. 
  • Store at room temperature, away from moisture and heat.

Recently viewed products